Potential disease-modifying therapy for Parkinson’s disease
Drug Discovery World
NOVEMBER 28, 2023
An experimental drug has shown potential as a disease-modifying therapy for Parkinson’s disease, according to a new study published in Nature Communications. Parkinson’s disease is highly associated with mitochondrial dysfunction. Mission is planning to initiate a MTX325 Phase I trial in humans in early 2024.
Let's personalize your content